Results 71 to 80 of about 401,372 (284)

Diagnosis and management of treatment-refractory hypothyroidism: an expert consensus report [PDF]

open access: yes, 2017
There is a frequently encountered subset of hypothyroid patients who are refractory to standard thyroid hormone replacement treatment and require unexpectedly high doses of levothyroxine.
Benvenga, S   +2 more
core   +1 more source

Increased Prevalence of Autoimmune Gastritis in Patients with a Gastric Precancerous Lesion

open access: yesJournal of Clinical Medicine, 2023
Background: Autoimmune gastritis (AIG), characterized with the presence of anti-parietal-cell antibodies (APCA), is a risk factor for gastric cancer. However, AIG may go underdiagnosed, especially in the case of H.
Xiaopei Guo   +11 more
semanticscholar   +1 more source

Expression of thyroglobulin on follicular dendritic cells of thyroid mucosa-associated lymphoid tissue (MALT) lymphoma [PDF]

open access: yes, 2009
Reportedly, thyroid mucosa-associated lymphoid tissue (MALT) lymphoma is closely associated with Hashimoto's thyroiditis. However, it remains unknown which antigen is closely associated with thyroid MALT lymphoma.
Akagi, Tadaatsu   +8 more
core   +1 more source

Autoimmune diseases in autoimmune atrophic gastritis.

open access: yesActa bio-medica : Atenei Parmensis, 2018
Autoimmune diseases, characterized by an alteration of the immune system which results in a loss of tolerance to self antigens often coexist in the same patient. Autoimmune atrophic gastritis, characterized by the development of antibodies agains parietal cells and against intrinsic factor, leads to mucosal destruction that affects primarily the corpus
Rodriguez-Castro, Kryssia Isabel   +8 more
openaire   +3 more sources

Conclusion that autoimmune gastritis does not predispose to gastric cancer is unproven

open access: yesGut, 2023
I read with great interest the paper by Rugge et al with the commentary by Goldenring challenging an old, established fact that autoimmune gastritis (AIG) (pernicious anaemia) predisposes to gastric adenocarcinoma.
H. Waldum
semanticscholar   +1 more source

The price of tumor control [PDF]

open access: yes, 2013
Ipilimumab, a cytotoxic T-lymphocyte antigen-4 (CTLA-4) blocking antibody, has been approved for the treatment of metastatic melanoma and induces adverse events (AE) in up to 64% of patients.
Bergmann, Tanja   +35 more
core   +1 more source

The price of tumor control: an analysis of rare side effects of anti-CTLA-4 therapy in metastatic melanoma from the ipilimumab network [PDF]

open access: yes, 2013
Background: Ipilimumab, a cytotoxic T-lymphocyte antigen-4 (CTLA-4) blocking antibody, has been approved for the treatment of metastatic melanoma and induces adverse events (AE) in up to 64% of patients.
A Bashey   +88 more
core   +4 more sources

Risk factors associated with the occurrence of autoimmune diseases in adult coeliac patients [PDF]

open access: yes, 2018
Objectives. Autoimmune diseases (AD) may be associated with coeliac disease (CD), but specific risk factors have been poorly investigated. The aim of this study was to assess the spectrum of AD and its specific risk factors associated in a series of ...
Annibale, Bruno   +5 more
core   +1 more source

Clinical case of autoimmune atrophic gastritis

open access: yesКлинический разбор в общей медицине
The article presents a clinical case of a 62-year-old female patient with a diagnosis of autoimmune atrophic gastritis, who has been troubled by symptoms of dyspepsia for 5 years.
Natalya N. Dekhnich   +3 more
doaj   +1 more source

Autoimmune gastritis, with or without pernicious anemia: epidemiology, risk factors, and clinical management

open access: yesTherapeutic Advances in Gastroenterology, 2021
Autoimmune gastritis (AIG) is a chronic immune-mediated, inflammatory condition that involves the destruction of the gastric oxyntic mucosa through the autoimmune-mediated loss of parietal cells, with replacement by atrophic and metaplastic tissue ...
S. Rustgi   +2 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy